Slow yoga breathing helped anxiety on top of usual psychiatric care in 150 patients

Most yoga research studies people who are basically well and wants to know whether they feel better. This one recruited 150 people with a psychiatric diagnosis, kept them all on their existing treatment, and added two things to half of them: slow breathing, and lying still.

Eight weeks later, improvements were noted only in the pranayama group: lower anxiety scores, better quality of life across three domains, less cortisol in the blood and more of a growth factor called BDNF. The other group carried on with routine psychiatric care and nothing else.

That gap is real. What produced it is the harder question, and the trial’s own design leaves it open.

Two practices, stripped out of the rest of yoga

Yoga as practiced in the United States typically emphasizes physical postures (asanas), breathing techniques (pranayama), and meditation (dyana). Most trials give people some combination of all three and then cannot say which part mattered.

Natarajan and colleagues took two components and left the rest. Slow pranayama is deliberately slowed breathing; savasana is the corpse pose, which involves lying on your back doing nothing on purpose. Neither requires flexibility, a mat, or the ability to stand up.

Their reason for isolating them is a gap in the literature: evidence isolating the effects of slow pranayama and savasana on psychological outcomes and biochemical markers in anxiety disorders remains limited.

There is a mechanical logic to picking breathing in particular. Anxiety runs partly through the autonomic nervous system, the branch that handles heart rate, sweating and the rest of the fight-or-flight apparatus without asking permission. Breathing is the one autonomic function you can seize manual control of at will, which makes slowing it down the closest thing the body has to a manual override on its own alarm system, and the reason this particular component was worth isolating.

Why an anxiety trial measured cortisol

The framing is physiological rather than psychological. Anxiety disorders are characterized by physiological dysregulation that includes heightened stress responses, low-grade systemic inflammation, and metabolic imbalance, and the researchers went looking for all three.

They measured serum cortisol, brain-derived neurotrophic factor, inflammatory markers and metabolic parameters alongside the Hamilton Anxiety Rating Scale and a World Health Organization quality-of-life questionnaire.

Two of those moved. Serum cortisol levels decreased and BDNF levels increased significantly in the intervention group compared with controls, which is the pattern you would predict if the practice were damping a stress response. The rest did not. Inflammatory and metabolic markers did not move once the threshold was tightened, although favorable directional trends were observed. The correction matters: when you test many outcomes, the bar for each one has to rise, and these markers did not clear the raised bar.

So the physiological story came back half-confirmed, which is more informative than a clean sweep would have been. A trial where every marker moves in the hoped-for direction usually means the analysis was too generous.

The anxiety control group did nothing at all

Here is what the comparison arm received: routine psychiatric care alone.

Not a sham breathing exercise. Not a stretching class, a discussion group, or a relaxation tape. Nothing added.

That design cannot distinguish the effect of slow breathing from the effect of having somewhere to be for eight weeks, being asked weekly how you are, and believing that the thing you have been given will work. In an outcome as expectation-sensitive as self-reported anxiety, those are not small forces. The cortisol result is the strongest thing here precisely because a hormone is harder to talk yourself into, and even that comes with a caveat: cortisol falls with relaxation of any kind, including the relaxation produced by expecting to relax. None of which makes the improvement fake. It makes the ingredient unidentified.

There is also attrition. 112 of the 150 completed, and the abstract does not say who left from where. A quarter of a trial walking away is enough to reshape a result if the leaving was uneven.

Where yoga breathing sits next to anxiety treatment

Nobody in this trial gave up their treatment, and that framing is the honest one. The main treatments for anxiety disorders are psychotherapy (talk therapy), medicines, or both, with cognitive behavioral therapy among the psychotherapies that teaches you different ways of thinking and behaving. Slow pranayama sits alongside those rather than against them. Natarajan and colleagues write that the practices appear to be safe, feasible, and effective adjuncts to standard psychiatric care.

Judged as an addition, the bar it has to clear is low. It costs nothing, needs no equipment, has no drug interactions, and can be done lying down by someone too anxious to leave the house. The National Center for Complementary and Integrative Health lists relieving stress and improving mental and emotional health among the things yoga may help with, which is a carefully hedged sentence and about right for the state of the evidence.

What would settle the pranayama question

A trial with an active control: the same eight weeks, the same attention, the same expectation of benefit, but breathing at an ordinary rate instead of a slowed one. Anything short of that leaves the specific ingredient unproven, however real the improvement. Publication in a specialty journal, the International Journal of Yoga Therapy, is worth knowing as context rather than as a verdict. The paper is paywalled, so the authors’ own limitations section was not available for this piece.

If you have anxiety and want to try slow breathing tonight, the evidence supports doing so as an extra. It does not support dropping anything you are already doing, and this trial did not test that, because nobody in it stopped their treatment.